EAT is up +49.38%% since April’24 pick View All Top Buy Picks
Currently predicting for Thu, 27 Jun 2024

Trading levels for GNFT.PA

Fibonacci Support & Resistance Levels

Level Price
R3 3.94 8.14%
R2 3.85 5.52%
R1 3.79 3.90%
Price 3.65
S1 3.60 -1.34%
S2 3.54 -2.96%
S3 3.44 -5.58%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.15 13.85%
R2 4.01 10.01%
R1 3.92 7.41%
Price 3.65
S1 3.47 -4.94%
S2 3.22 -11.66%
S3 3.20 -12.21%

GNFT.PA Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Genfit SA

Genfit SA Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat ... GNFT.PA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT